Global Predictive and Presymptomatic Testing Market Research Report 2024

Publication ID:

PB504242781

Publication Date:

April 11, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Predictive genetic testing searches for genetic changes, or mutations, that are linked to disease. These tests are done before you show any signs of a disease.听
The global Predictive and Presymptomatic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Predictive and Presymptomatic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Predictive and Presymptomatic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Predictive and Presymptomatic Testing in Breast and Ovarian Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Predictive and Presymptomatic Testing include 23andMe, Inc., Abbott Molecular, Inc., BioAxis DNA Research Centre Private Limited, Color Genomics, Inc., Direct Laboratory Services LLC (DirectLabs), Gene by Gene Ltd., Genomic Diagnostics, Mapmygenome and Myriad Genetics, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Predictive and Presymptomatic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Predictive and Presymptomatic Testing.
Report Scope
The Predictive and Presymptomatic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Predictive and Presymptomatic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Predictive and Presymptomatic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
23andMe, Inc.
Abbott Molecular, Inc.
BioAxis DNA Research Centre Private Limited
Color Genomics, Inc.
Direct Laboratory Services LLC (DirectLabs)
Gene by Gene Ltd.
Genomic Diagnostics
Mapmygenome
Myriad Genetics, Inc.
Pathway Genomics Corporation
Positive Bioscience, Inc.
Quest Diagnostics, Inc.
Segment by Type
Presymptomatic Testing
Predispositional Testing
Segment by Application
Breast and Ovarian Cancer
Colorectal Cancer
Alzheimer's Disease
Multiple Endocrine Neoplasia Type 2
Haemochromatosis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Predictive and Presymptomatic Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Predictive and Presymptomatic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Presymptomatic Testing
1.2.3 Predispositional Testing
1.3 Market by Application
1.3.1 Global Predictive and Presymptomatic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Breast and Ovarian Cancer
1.3.3 Colorectal Cancer
1.3.4 Alzheimer's Disease
1.3.5 Multiple Endocrine Neoplasia Type 2
1.3.6 Haemochromatosis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Predictive and Presymptomatic Testing Market Perspective (2019-2030)
2.2 Predictive and Presymptomatic Testing Growth Trends by Region
2.2.1 Global Predictive and Presymptomatic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Predictive and Presymptomatic Testing Historic Market Size by Region (2019-2024)
2.2.3 Predictive and Presymptomatic Testing Forecasted Market Size by Region (2025-2030)
2.3 Predictive and Presymptomatic Testing Market Dynamics
2.3.1 Predictive and Presymptomatic Testing Industry Trends
2.3.2 Predictive and Presymptomatic Testing Market Drivers
2.3.3 Predictive and Presymptomatic Testing Market Challenges
2.3.4 Predictive and Presymptomatic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Predictive and Presymptomatic Testing Players by Revenue
3.1.1 Global Top Predictive and Presymptomatic Testing Players by Revenue (2019-2024)
3.1.2 Global Predictive and Presymptomatic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Predictive and Presymptomatic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Predictive and Presymptomatic Testing Revenue
3.4 Global Predictive and Presymptomatic Testing Market Concentration Ratio
3.4.1 Global Predictive and Presymptomatic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Predictive and Presymptomatic Testing Revenue in 2023
3.5 Predictive and Presymptomatic Testing Key Players Head office and Area Served
3.6 Key Players Predictive and Presymptomatic Testing Product Solution and Service
3.7 Date of Enter into Predictive and Presymptomatic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Predictive and Presymptomatic Testing Breakdown Data by Type
4.1 Global Predictive and Presymptomatic Testing Historic Market Size by Type (2019-2024)
4.2 Global Predictive and Presymptomatic Testing Forecasted Market Size by Type (2025-2030)
5 Predictive and Presymptomatic Testing Breakdown Data by Application
5.1 Global Predictive and Presymptomatic Testing Historic Market Size by Application (2019-2024)
5.2 Global Predictive and Presymptomatic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Predictive and Presymptomatic Testing Market Size (2019-2030)
6.2 North America Predictive and Presymptomatic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Predictive and Presymptomatic Testing Market Size by Country (2019-2024)
6.4 North America Predictive and Presymptomatic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Predictive and Presymptomatic Testing Market Size (2019-2030)
7.2 Europe Predictive and Presymptomatic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Predictive and Presymptomatic Testing Market Size by Country (2019-2024)
7.4 Europe Predictive and Presymptomatic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Predictive and Presymptomatic Testing Market Size (2019-2030)
8.2 Asia-Pacific Predictive and Presymptomatic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Predictive and Presymptomatic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Predictive and Presymptomatic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Predictive and Presymptomatic Testing Market Size (2019-2030)
9.2 Latin America Predictive and Presymptomatic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Predictive and Presymptomatic Testing Market Size by Country (2019-2024)
9.4 Latin America Predictive and Presymptomatic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Predictive and Presymptomatic Testing Market Size (2019-2030)
10.2 Middle East & Africa Predictive and Presymptomatic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Predictive and Presymptomatic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Predictive and Presymptomatic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 23andMe, Inc.
11.1.1 23andMe, Inc. Company Detail
11.1.2 23andMe, Inc. Business Overview
11.1.3 23andMe, Inc. Predictive and Presymptomatic Testing Introduction
11.1.4 23andMe, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.1.5 23andMe, Inc. Recent Development
11.2 Abbott Molecular, Inc.
11.2.1 Abbott Molecular, Inc. Company Detail
11.2.2 Abbott Molecular, Inc. Business Overview
11.2.3 Abbott Molecular, Inc. Predictive and Presymptomatic Testing Introduction
11.2.4 Abbott Molecular, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.2.5 Abbott Molecular, Inc. Recent Development
11.3 BioAxis DNA Research Centre Private Limited
11.3.1 BioAxis DNA Research Centre Private Limited Company Detail
11.3.2 BioAxis DNA Research Centre Private Limited Business Overview
11.3.3 BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Introduction
11.3.4 BioAxis DNA Research Centre Private Limited Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.3.5 BioAxis DNA Research Centre Private Limited Recent Development
11.4 Color Genomics, Inc.
11.4.1 Color Genomics, Inc. Company Detail
11.4.2 Color Genomics, Inc. Business Overview
11.4.3 Color Genomics, Inc. Predictive and Presymptomatic Testing Introduction
11.4.4 Color Genomics, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.4.5 Color Genomics, Inc. Recent Development
11.5 Direct Laboratory Services LLC (DirectLabs)
11.5.1 Direct Laboratory Services LLC (DirectLabs) Company Detail
11.5.2 Direct Laboratory Services LLC (DirectLabs) Business Overview
11.5.3 Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Introduction
11.5.4 Direct Laboratory Services LLC (DirectLabs) Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.5.5 Direct Laboratory Services LLC (DirectLabs) Recent Development
11.6 Gene by Gene Ltd.
11.6.1 Gene by Gene Ltd. Company Detail
11.6.2 Gene by Gene Ltd. Business Overview
11.6.3 Gene by Gene Ltd. Predictive and Presymptomatic Testing Introduction
11.6.4 Gene by Gene Ltd. Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.6.5 Gene by Gene Ltd. Recent Development
11.7 Genomic Diagnostics
11.7.1 Genomic Diagnostics Company Detail
11.7.2 Genomic Diagnostics Business Overview
11.7.3 Genomic Diagnostics Predictive and Presymptomatic Testing Introduction
11.7.4 Genomic Diagnostics Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.7.5 Genomic Diagnostics Recent Development
11.8 Mapmygenome
11.8.1 Mapmygenome Company Detail
11.8.2 Mapmygenome Business Overview
11.8.3 Mapmygenome Predictive and Presymptomatic Testing Introduction
11.8.4 Mapmygenome Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.8.5 Mapmygenome Recent Development
11.9 Myriad Genetics, Inc.
11.9.1 Myriad Genetics, Inc. Company Detail
11.9.2 Myriad Genetics, Inc. Business Overview
11.9.3 Myriad Genetics, Inc. Predictive and Presymptomatic Testing Introduction
11.9.4 Myriad Genetics, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.9.5 Myriad Genetics, Inc. Recent Development
11.10 Pathway Genomics Corporation
11.10.1 Pathway Genomics Corporation Company Detail
11.10.2 Pathway Genomics Corporation Business Overview
11.10.3 Pathway Genomics Corporation Predictive and Presymptomatic Testing Introduction
11.10.4 Pathway Genomics Corporation Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.10.5 Pathway Genomics Corporation Recent Development
11.11 Positive Bioscience, Inc.
11.11.1 Positive Bioscience, Inc. Company Detail
11.11.2 Positive Bioscience, Inc. Business Overview
11.11.3 Positive Bioscience, Inc. Predictive and Presymptomatic Testing Introduction
11.11.4 Positive Bioscience, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.11.5 Positive Bioscience, Inc. Recent Development
11.12 Quest Diagnostics, Inc.
11.12.1 Quest Diagnostics, Inc. Company Detail
11.12.2 Quest Diagnostics, Inc. Business Overview
11.12.3 Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Introduction
11.12.4 Quest Diagnostics, Inc. Revenue in Predictive and Presymptomatic Testing Business (2019-2024)
11.12.5 Quest Diagnostics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

23andMe, Inc.
Abbott Molecular, Inc.
BioAxis DNA Research Centre Private Limited
Color Genomics, Inc.
Direct Laboratory Services LLC (DirectLabs)
Gene by Gene Ltd.
Genomic Diagnostics
Mapmygenome
Myriad Genetics, Inc.
Pathway Genomics Corporation
Positive Bioscience, Inc.
Quest Diagnostics, Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂